Treatment of vascular dementia: The route of prevention

被引:60
作者
Sorrentino, G. [1 ,2 ]
Migliaccio, R. [2 ,3 ]
Bonavita, V. [2 ,4 ]
机构
[1] Univ Naples Parthenope, Naples, Italy
[2] Ist Diagnosi Cura Hermitage Capodimonte, Naples, Italy
[3] Univ Naples 2, Naples, Italy
[4] Univ Naples Federico II, Naples, Italy
关键词
vascular dementia; prevention; hypertension; hypercholesterolemia; diabetes; hyperhomocysteinemia; Alzheimer's disease; mixed dementia;
D O I
10.1159/000151696
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Vascular dementia (VaD), rather than being considered as a univocal nosological entity, should be regarded as a heterogeneous clinical entity which differs in clinical-pathological phenotype as well as in pathophysiological mechanisms, but shares cerebrovascular disease (CVD), resulting from vascular or circulatory pathology, as the cause of dementia. The aim of this review is to discuss VaD treatment focusing particularly on more prevalent ischemic forms. Due to the fact that there are presently no treatments capable of obtaining considerable results once VaD is clinically established, specific emphasis will be given to the therapeutic strategies aimed at the prevention of CVD risk factors. The therapeutic strategies aimed at slowing the progression of the disease will also be discussed. Copyright (C) 2008 S. Karger AG, Basel.
引用
收藏
页码:217 / 223
页数:7
相关论文
共 60 条
[1]
Stroke prevention, blood cholesterol, and statins [J].
Amarenco, P ;
Lavallée, P ;
Touboul, PJ .
LANCET NEUROLOGY, 2004, 3 (05) :271-278
[2]
[Anonymous], 2000, J Atheroscler Thromb, V7, P110
[3]
[Anonymous], 2002, JAMA
[4]
[Anonymous], 1994, BMJ, V308, P81, DOI [10.1136/bmj.308.6921.81, DOI 10.1136/BMJ.308.6921.81]
[5]
[Anonymous], COCHRANE DATABASE SY
[6]
[Anonymous], 2000, Lancet, V355, P253, DOI DOI 10.1016/S0140-6736(99)12323-7
[7]
Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention - The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study [J].
Athyros, VG ;
Papageorgiou, AA ;
Mercouris, BR ;
Athyrou, VV ;
Symeonidis, AN ;
Basayannis, EO ;
Demitriadis, DS ;
Kontopoulos, AG .
CURRENT MEDICAL RESEARCH AND OPINION, 2002, 18 (04) :220-228
[8]
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J].
Baigent, C ;
Keech, A ;
Kearney, PM ;
Blackwell, L ;
Buck, G ;
Pollicino, C ;
Kirby, A ;
Sourjina, T ;
Peto, R ;
Collins, R ;
Simes, J .
LANCET, 2005, 366 (9493) :1267-1278
[9]
Collins R, 2004, LANCET, V363, P757
[10]
Alzheimer disease as a vascular disorder - Nosological evidence [J].
de la Torre, JC .
STROKE, 2002, 33 (04) :1152-1162